Long-term effects of childhood solid tumors and their treatments in survivors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The French Childhood Cancer Survivor Study (FCCSS) is a large-scale observational study that focuses on children treated for solid tumors in France before the year 2000. It aims to improve understanding of the long-term health and social outcomes of these survivors, including the risk of second malignancies and other health issues related to cancer treatments. The study will follow a cohort of survivors for up to 20 years, utilizing medical records, national registries, and self-questionnaires to gather comprehensive data on their health and quality of life. By identifying high-risk patients and comparing their mortality rates with the general population, the FCCSS seeks to inform better follow-up care and preventive measures.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All types of solid childhood cancer in France
* Age at diagnosis: Below age 19
* Period of diagnosis: between 1st January 1942 and 31st December 1999
* Complete identification (first name, last name, date of birth and place of birth)

Exclusion Criteria:

* Leukaemia cases

Where it's running

• Centre Antoine Lacassagne
  Nice, France Recruiting
• Institut Curie
  Paris, France Recruiting
• Institut Jean Godinot
  Reims, France Recruiting
• Institut Claudius Regaud
  Toulouse, France Recruiting
• Institut Gustave Roussy
  Villejuif, France Recruiting
• Centre Hospital-Universitaire Hôpital Nord
  Amiens, France Active not recruiting

Study contacts

• Principal investigator: Florent F. de Vathaire, Ph.D. — Institut National de la Santé Et de la Recherche Médicale, France
• Study coordinator: Florent F. de Vathaire, Ph.D
• Email: florent.devathaire@igr.fr

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Targeted therapies for childhood and adolescent cancer

  This study is testing if new targeted treatments based on the genetic makeup of tumors can help kids and teens with cancer feel better and improve their chances of recovery.

  Recruiting at 12 sites Phase 1/2 Australian & New Zealand Children's Haematology/Oncology Group · Newcastle, New South Wales and 13 other locations · NCT06208657

• Precision medicine for children with cancer

  This study is testing if personalized medicine can improve treatment and outcomes for children with different types of cancer in Australia and New Zealand.

  Recruiting at 10 sites Australian & New Zealand Children's Haematology/Oncology Group · Adelaide and 10 other locations · NCT05504772

• Exploring immune responses to cell therapy in tumors

  This study is testing how the immune system reacts to a new cell therapy in patients with different types of tumors to see if these reactions can help predict how well the treatment works and what side effects might occur.

  Recruiting Gustave Roussy, Cancer Campus, Grand Paris · Villejuif, Val de Marne · NCT05481502

• Using Nivolumab after Half-Matched Bone Marrow Transplant for Sarcoma

  This study is testing if a new drug called Nivolumab can help prevent or delay the return of high-risk sarcomas in children and adults after they receive a special type of bone marrow transplant.

  Recruiting at 3 sites Phase 1/2 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · St. Petersburg, Florida and 3 other locations · NCT03465592

• Collecting and storing tissue samples from patients with suspected solid tumors

  This study is collecting blood and tissue samples from patients with suspected solid tumors to help with future cancer research and understand how normal tissue changes to cancerous tissue.

  Recruiting Wake Forest University Health Sciences · Winston-Salem, North Carolina · NCT00900471

• Quality of End-of-Life Care for Children With Cancer

  This study looks at how access to care, family interactions with the healthcare system, and stress relate to the quality of end-of-life care for children with cancer.

  Recruiting at 28 sites Children's Oncology Group · Birmingham, Alabama and 27 other locations · NCT07412002

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.